TRYP THERAPEUTICS
Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs. Tryp's psilocybin-for-neuropsychiatric disorders, or PFN™, program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders.
TRYP THERAPEUTICS
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Kelowna, British Columbia, Canada
Country:
Canada
Website Url:
http://www.tryptherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
7.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Font Awesome Mobile Non Scaleable Content Nginx Google Apps For Business Cloudflare JS CDN JS
Similar Organizations
Aclipse Therapeutics
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Asalyxa Bio
Asalyxa Bio is committed to developing neutrophil targeting treatments for diseases with a high unmet medical need.
Cognition Therapeutics
Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Teclison
Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Marc Lustig
Marc Lustig investment in Post-IPO Equity - Tryp Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-23 | Tryp Therapeutics Appoints New Chief Operating Officer |
Official Site Inspections
http://www.tryptherapeutics.com Semrush global rank: 6.28 M Semrush visits lastest month: 1.19 K
- Host name: syn05be.syd6.hostyourservices.net
- IP address: 110.232.143.82
- Location: Brisbane Australia
- Latitude: -27.4732
- Longitude: 153.0215
- Timezone: Australia/Brisbane
- Postal: 4000
